New drug MAR001 targets high triglycerides in early trial
Disease control
Completed
This early-stage study tested the safety and tolerability of a new drug called MAR001 in 55 adults with high triglycerides (a type of fat in the blood). The main goal was to see if the drug is safe, and researchers also checked whether it lowers triglyceride levels. The study was…
Phase: PHASE1, PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC